EligibleTrials

Clinical trials recruiting for Gall Bladder Cancer

8
Recruiting trials
25
US states with sites
11
Countries
12%
Accept healthy volunteers

Phase breakdown

Phase 1 2Phase 2 3Not applicable 5

Drugs and treatments being studied

InterventionTrials
Atezolizumab1
Pembrolizumab1
Tivozanib1
Trastuzumab deruxtecan1
chemotherapy with gemcitabine and oxaliplatin; small molecure TKI lenvatinib; immune-checkpoint inhibitor toripalimab.1
rezatapopt1

Where trials are recruiting (top US states)

StateRecruiting trials
California4
Florida3
North Carolina3
Pennsylvania3
Colorado2
Massachusetts2
Ohio2
Tennessee2
Texas2
Alabama1
Arizona1
Connecticut1

Top cities

Boston, Massachusetts 2Dallas, Texas 2Durham, North Carolina 2Nashville, Tennessee 2Philadelphia, Pennsylvania 2Pittsburgh, Pennsylvania 2Sacramento, California 2Austin, Texas 1Bedford, Texas 1Birmingham, Alabama 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Gall Bladder Cancer often also study these conditions. Each links to its own recruiting-trial list.

Lung cancer 2180Prostate cancer 1234Ovarian cancer 118Colorectal cancer 1359Intrahepatic Cholangiocarcinoma (Icc) 17Hypertension 1201Head and neck cancer 62Endometrial cancer 68Breast cancer 2239Vulvar Cancer 8

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Gall Bladder Cancer trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.